Literature DB >> 33510259

iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities.

Hugo Poulin1, Aurélie Mercier1, Mohammed Djemai1, Valérie Pouliot1, Isabelle Deschenes2, Mohamed Boutjdir3,4,5, Jack Puymirat6, Mohamed Chahine7,8.   

Abstract

Cardiac complications such as electrical abnormalities including conduction delays and arrhythmias are the main cause of death in individuals with Myotonic Dystrophy type 1 (DM1). We developed a disease model using iPSC-derived cardiomyocytes (iPSC-CMs) from a healthy individual and two DM1 patients with different CTG repeats lengths and clinical history (DM1-1300 and DM1-300). We confirmed the presence of toxic RNA foci and mis-spliced MBNL1/2 transcripts in DM1 iPSC-CMs. In DM1-1300, we identified a switch in the cardiac sodium channel SCN5A from the adult to the neonatal isoform. The down-regulation of adult SCN5A isoforms is consistent with a shift in the sodium current activation to depolarized potentials observed in DM1-1300. L-type calcium current density was higher in iPSC-CMs from DM1-1300, which is correlated with the overexpression of the CaV1.2 transcript and proteins. Importantly, INa and ICaL dysfunctions resulted in prolonged action potentials duration, slower velocities, and decreased overshoots. Optical mapping analysis revealed a slower conduction velocity in DM1-1300 iPSC-CM monolayers. In conclusion, our data revealed two distinct ions channels perturbations in DM1 iPSC-CM from the patient with cardiac dysfunction, one affecting Na+ channels and one affecting Ca2+ channels. Both have an impact on cardiac APs and ultimately on heart conduction.

Entities:  

Year:  2021        PMID: 33510259      PMCID: PMC7844414          DOI: 10.1038/s41598-021-82007-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  46 in total

1.  Analysis of the Z-disc genes PDLIM3 and MYPN in patients with hypertrophic cardiomyopathy.

Authors:  Richard D Bagnall; Laura Yeates; Christopher Semsarian
Journal:  Int J Cardiol       Date:  2010-12-03       Impact factor: 4.164

2.  Nav1.5 channels can reach the plasma membrane through distinct N-glycosylation states.

Authors:  Aurélie Mercier; Romain Clément; Thomas Harnois; Nicolas Bourmeyster; Patrick Bois; Aurélien Chatelier
Journal:  Biochim Biophys Acta       Date:  2015-02-23

3.  A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties.

Authors:  Romy Siegert; Andreas Perrot; Sandro Keller; Joachim Behlke; Aleksandra Michalewska-Włudarczyk; Anna Wycisk; Michal Tendera; Ingo Morano; Cemil Ozcelik
Journal:  Biochem Biophys Res Commun       Date:  2011-01-20       Impact factor: 3.575

4.  Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.

Authors:  Ellis Y Kim; David Y Barefield; Andy H Vo; Anthony M Gacita; Emma J Schuster; Eugene J Wyatt; Janel L Davis; Biqin Dong; Cheng Sun; Patrick Page; Lisa Dellefave-Castillo; Alexis Demonbreun; Hao F Zhang; Elizabeth M McNally
Journal:  JCI Insight       Date:  2019-03-21

5.  Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.

Authors:  Michinori Koebis; Natsumi Ohsawa; Yoshihiro Kino; Noboru Sasagawa; Ichizo Nishino; Shoichi Ishiura
Journal:  Genes Cells       Date:  2011-07-28       Impact factor: 1.891

6.  Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.

Authors:  Xiaoyan Lin; Jill W Miller; Ami Mankodi; Rahul N Kanadia; Yuan Yuan; Richard T Moxley; Maurice S Swanson; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2006-05-22       Impact factor: 6.150

Review 7.  Myotonic dystrophy: RNA-mediated muscle disease.

Authors:  Thurman M Wheeler; Charles A Thornton
Journal:  Curr Opin Neurol       Date:  2007-10       Impact factor: 5.710

8.  Splicing biomarkers of disease severity in myotonic dystrophy.

Authors:  Masayuki Nakamori; Krzysztof Sobczak; Araya Puwanant; Steve Welle; Katy Eichinger; Shree Pandya; Jeannne Dekdebrun; Chad R Heatwole; Michael P McDermott; Tian Chen; Melissa Cline; Rabi Tawil; Robert J Osborne; Thurman M Wheeler; Maurice S Swanson; Richard T Moxley; Charles A Thornton
Journal:  Ann Neurol       Date:  2013-12       Impact factor: 10.422

9.  Determinants of myocardial conduction velocity: implications for arrhythmogenesis.

Authors:  James H King; Christopher L-H Huang; James A Fraser
Journal:  Front Physiol       Date:  2013-06-28       Impact factor: 4.566

10.  MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases.

Authors:  A Botta; A Malena; E Tibaldi; L Rocchi; E Loro; E Pena; L Cenci; E Ambrosi; M C Bellocchi; M A Pagano; G Novelli; G Rossi; H L Monaco; E Gianazza; B Pantic; V Romeo; O Marin; A M Brunati; L Vergani
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

View more
  4 in total

1.  Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1.

Authors:  Siham Ait Benichou; Dominic Jauvin; Thiéry De Serres-Bérard; Marion Pierre; Karen K Ling; C Frank Bennett; Frank Rigo; Genevieve Gourdon; Mohamed Chahine; Jack Puymirat
Journal:  Gene Ther       Date:  2022-01-25       Impact factor: 5.250

Review 2.  Neuromuscular Development and Disease: Learning From in vitro and in vivo Models.

Authors:  Zachary Fralish; Ethan M Lotz; Taylor Chavez; Alastair Khodabukus; Nenad Bursac
Journal:  Front Cell Dev Biol       Date:  2021-10-27

Review 3.  Cardiac Pathology in Myotonic Dystrophy Type 1.

Authors:  Mani S Mahadevan; Ramesh S Yadava; Mahua Mandal
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

4.  LMNA mutation leads to cardiac sodium channel dysfunction in the Emery-Dreifuss muscular dystrophy patient.

Authors:  Kseniya Perepelina; Anastasia Zaytseva; Aleksandr Khudiakov; Irina Neganova; Elena Vasichkina; Anna Malashicheva; Anna Kostareva
Journal:  Front Cardiovasc Med       Date:  2022-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.